July BNF/BNFC Newsletter

Monograph on darolutamide has been added to the BNF, as well as MHRA advice on cyproterone acetate, lenalidomide, pomalidomide, sodium valproate, thalidomide and valproic acid. Updates to both BNF and BNFC include management of hypo- and hyperthyroidism.

British National Formulary